aacrjournals.org/clincancerre...
aacrjournals.org/clincancerre...
➡️Watch their full talk youtube.com/watch?v=9C1m....
➡️Watch their full talk youtube.com/watch?v=9C1m....
RSVP: bit.ly/MHNCS26-T
@peerview.bsky.social
RSVP: bit.ly/MHNCS26-T
@peerview.bsky.social
medicine.yale.edu/cancer/news-...
medicine.yale.edu/cancer/news-...
ascopubs.org/do/associati...
@ascocancer.bsky.social
ascopubs.org/do/associati...
@ascocancer.bsky.social
Stop by Smilow Auditorium or watch online: bit.ly/4bSWNxF.
Stop by Smilow Auditorium or watch online: bit.ly/4bSWNxF.
📻Live #WNPR
🔁Download #ApplePodcasts
💻Listen later #YouTube
📻Live #WNPR
🔁Download #ApplePodcasts
💻Listen later #YouTube
and Elizabeth Prsic, will present “A Comprehensive Approach to Optimizing Care for the Hospitalized Cancer Patient” at the Association of Cancer Executives (ACE) Annual Meeting on Monday, Jan. 26 at 9:45am PT. #ACE26
and Elizabeth Prsic, will present “A Comprehensive Approach to Optimizing Care for the Hospitalized Cancer Patient” at the Association of Cancer Executives (ACE) Annual Meeting on Monday, Jan. 26 at 9:45am PT. #ACE26
nytimes.com/2026/01/22/h...
#lcsm @nytimes.com
nytimes.com/2026/01/22/h...
#lcsm @nytimes.com
medicine.yale.edu/news-article...
@zongmingma.bsky.social @yalepathology.bsky.social
medicine.yale.edu/news-article...
@zongmingma.bsky.social @yalepathology.bsky.social
and Samir Zaidi, recipients of Young Physician-Scientist Awards from @the-asci.org!
beta.the-asci.org/news/uncateg...
and Samir Zaidi, recipients of Young Physician-Scientist Awards from @the-asci.org!
beta.the-asci.org/news/uncateg...
medicine.yale.edu/news-article...
medicine.yale.edu/news-article...
🎧Listen live #WNPR
🔁Download #ApplePodcasts
💻Listen later #YouTube
🎧Listen live #WNPR
🔁Download #ApplePodcasts
💻Listen later #YouTube
medicine.yale.edu/news-article...
medicine.yale.edu/news-article...
for presenting #GrandRounds on potential programs to reveal and exploit the strategies nature uses to combat #cancer, including the impact of #p53 in #tumorsuppression.
Watch his full talk: youtube.com/watch?v=B6pj....
for presenting #GrandRounds on potential programs to reveal and exploit the strategies nature uses to combat #cancer, including the impact of #p53 in #tumorsuppression.
Watch his full talk: youtube.com/watch?v=B6pj....
medicine.yale.edu/news-article...
medicine.yale.edu/news-article...
Tune in to #SmilowShares on #YouTube to hear experts discuss management strategies and the evolving role of neoadjuvant therapy.
▶️ Watch: youtu.be/_nNJAgbxaIU?...
Tune in to #SmilowShares on #YouTube to hear experts discuss management strategies and the evolving role of neoadjuvant therapy.
▶️ Watch: youtu.be/_nNJAgbxaIU?...
@mskcancercenter.bsky.social as our #GrandRounds lecturer, presenting "Targeting the intersection between senescence and cancer." Join us in Smilow Auditorium or online via Zoom: bit.ly/49lM8u1.
@mskcancercenter.bsky.social as our #GrandRounds lecturer, presenting "Targeting the intersection between senescence and cancer." Join us in Smilow Auditorium or online via Zoom: bit.ly/49lM8u1.
@yale-hematology.bsky.social shows subcutaneous alnuctamab #ALNUC is active in #RRMM, with a 58–71% response rate, ~50% of patients achieving MRD negativity, and better safety than IV dosing. #multiplemyeloma
www.nature.com/articles/s41...
@yale-hematology.bsky.social shows subcutaneous alnuctamab #ALNUC is active in #RRMM, with a 58–71% response rate, ~50% of patients achieving MRD negativity, and better safety than IV dosing. #multiplemyeloma
www.nature.com/articles/s41...
@ascocancer.bsky.social
@ascocancer.bsky.social
presented research on ALK fusions in #colorectalcancer.
meetings.asco.org/meetings/202...
@ascocancer.bsky.social
presented research on ALK fusions in #colorectalcancer.
meetings.asco.org/meetings/202...
@ascocancer.bsky.social
@ascocancer.bsky.social
@ascocancer.bsky.social
medicine.yale.edu/cancer/news-...
medicine.yale.edu/cancer/news-...